A role for the neurexin-neuroligin complex in Alzheimer's disease

Neurobiology of Aging

Volumn 35, Issue 4, 2014, Pages 746-756

  Sindi, Ikhlas A ^a   Tannenberg, Rudolph K ^a   Dodd, Peter R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Acetylcholinesterase (AChE); Alternative splicing; Cell adhesion molecules; Excitatory synapses; Inhibitory synapses; Neurodegeneration

Indexed keywords

AMYLOID BETA PROTEIN; NEUREXIN; NEUROLIGIN;

ALZHEIMER DISEASE; DISEASE COURSE; DNA PROTEIN COMPLEX; GENETIC CODE; HUMAN; NERVE CELL PLASTICITY; NERVE CELL STIMULATION; NEUROFIBRILLARY TANGLE; NONHUMAN; OLIGOMERIZATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; RNA SPLICING;

ACETYLCHOLINESTERASE (ACHE); ALTERNATIVE SPLICING; CELL ADHESION MOLECULES; EXCITATORY SYNAPSES; INHIBITORY SYNAPSES; NEURODEGENERATION;

ACETYLCHOLINESTERASE; ALTERNATIVE SPLICING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BRAIN; CELL ADHESION MOLECULES, NEURONAL; CELL COMMUNICATION; DISEASE PROGRESSION; HUMANS; LEARNING; MEMORY; NERVE TISSUE PROTEINS; NEURAL CELL ADHESION MOLECULES; NEURONAL PLASTICITY; NEURONS; SYNAPSES;

EID: 84891372071     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.09.032     Document Type: Review

References (127)

1. Akiyama H., Kawamata T., Dedhar S., McGeer P.L. Immunohistochemical localization of vitronectin, its receptor and β-3 integrin in Alzheimer brain tissue. J. Neuroimmunol. 1991, 32:19-28.
2. Alonso-Nanclares L., Merino-Serrais P., Gonzalez S., DeFelipe J. Synaptic changes in the dentate gyrus of APP/PS1 transgenic mice revealed by electron microscopy. J.Neuropathol. Exp. Neurol. 2013, 72:386-395.
3. Ando K., Uemura K., Kuzuya A., Maesako M., Asada-Utsugi M., Kubota M., Aoyagi N., Yoshioka K., Okawa K., Inoue H., Kawamata J., Shimohama S., Arai T., Takahashi R., Kinoshita A. N-cadherin regulates p38 MAPK signaling via association with JNK-associated leucine zipper protein: implications for neurodegeneration in Alzheimer disease. J.Biol. Chem. 2011, 286:7619-7628.
4. Andres C., Beeri R., Friedman A., Lev-Lehman E., Henis S., Timberg R., Shani M., Soreq H. Acetylcholinesterase-transgenic mice display embryonic modulations in spinal cord choline acetyltransferase and neurexin Iß gene expression followed by late-onset neuromotor deterioration. Proc. Natl. Acad. Sci. U.S.A 1997, 94:8173-8178.
5. Andreyeva A., Nieweg K., Horstmann K., Klapper S., Muller-Schiffmann A., Korth C., Gottmann K. C-terminal fragment of N-cadherin accelerates synapse destabilization by amyloid-ß. Brain 2012, 135:2140-2154.
6. Arking D.E., Cutler D.J., Brune C.W., Teslovich T.M., West K., Ikeda M., Rea A., Guy M., Lin S., Cook E.H., Chakravarti A. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am. J. Hum. Genet. 2008, 82:160-164.
7. Asada-Utsugi M., Uemura K., Noda Y., Kuzuya A., Maesako M., Ando K., Kubota M., Watanabe K., Takahashi M., Kihara T., Shimohama S., Takahashi R., Berezovska O., Kinoshita A. N-cadherin enhances APP dimerization at the extracellular domain and modulates Aß production. J.Neurochem. 2011, 119:354-363.
8. Ashe K.H. Learning and memory in transgenic mice modeling Alzheimer's disease. Learn. Mem. 2001, 8:301-308.
9. Bamji S.X., Shimazu K., Kimes N., Huelsken J., Birchmeier W., Lu B., Reichardt L.F. Role of ß-catenin in synaptic vesicle localization and presynaptic assembly. Neuron 2003, 40:719-731.
10. Bancher C., Braak H., Fischer P., Jellinger K.A. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci. Lett. 1993, 162:179-182.
11. Blundell J., Blaiss C.A., Etherton M.R., Espinosa F., Tabuchi K., Walz C., Bolliger M.F., Südhof T.C., Powell C.M. Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior. J.Neurosci. 2010, 30:2115-2129.
12. Boller F., Forbes M.M. History of dementia and dementia in history: an overview. J.Neurol. Sci. 1998, 158:125-133.
13. Bolliger M.F., Frei K., Winterhalter K.H., Gloor S.M. Identification of a novel neuroligin in humans which binds to PSD-95 and has a widespread expression. Biochem. J. 2001, 356:581-588.
14. Bot N., Schweizer C., Ben Halima S., Fraering P.C. Processing of the synaptic cell adhesion molecule neurexin-3ß by Alzheimer disease α- and γ-secretases. J.Biol. Chem. 2011, 286:2762-2773.
15. Boucard A.A., Chubykin A.A., Comoletti D., Taylor P., Südhof T.C. Asplice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to α and β-neurexins. Neuron 2005, 48:229-236.
16. Buttini M., Masliah E., Barbour R., Grajeda H., Motter R., Johnson-Wood K., Khan K., Seubert P., Freedman S., Schenk D., Games D. β-Amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease. J.Neurosci. 2005, 25:9096-9101.
17. Cartier A.E., Djakovic S.N., Salehi A., Wilson S.M., Masliah E., Patrick G.N. Regulation of synaptic structure by ubiquitin C-terminal hydrolase L1. J.Neurosci. 2009, 29:7857-7868.
18. Chapman P.F., Falinska A.M., Knevett S.G., Ramsay M.F. Genes, models and Alzheimer's disease. Trends Genet. 2001, 17:254-261.
19. Chih B., Engelman H., Scheiffele P. Control of excitatory and inhibitory synapse formation by neuroligins. Science 2005, 307:1324-1328.
20. Chih B., Gollan L., Scheiffele P. Alternative splicing controls selective trans-synaptic interactions of the neuroligin-neurexin complex. Neuron 2006, 51:171-178.
21. Choi Y.B., Li H.L., Kassabov S.R., Jin I., Puthanveettil S.V., Karl K.A., Lu Y., Kim J.H., Bailey C.H., Kandel E.R. Neurexin-neuroligin transsynaptic interaction mediates learning-related synaptic remodeling and long-term facilitation in aplysia. Neuron 2011, 70:468-481.
22. Cirrito J.R., Yamada K.A., Finn M.B., Sloviter R.S., Bales K.R., May P.C., Schoepp D.D., Paul S.M., Mennerick S., Holtzman D.M. Synaptic activity regulates interstitial fluid amyloid-β levels invivo. Neuron 2005, 48:913-922.
23. Clark L.N., Poorkaj P., Wszolek Z., Geschwind D.H., Nasreddine Z.S., Miller B., Li D., Payami H., Awert F., Markopoulou K., Andreadis A., Dsouza I., Lee V.M.Y., Reed L., Trojanowski J.Q., Zhukareva V., Bird T., Schellenberg G., Wilhelmsen K.C. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc. Natl. Acad. Sci. U.S.A 1998, 95:13103-13107.
24. Comoletti D., Flynn R., Jennings L.L., Chubykin A., Matsumura T., Hasegawa H., Südhof T.C., Taylor P. Characterization of the interaction of a recombinant soluble neuroligin-1 with neurexin-1β. J.Biol. Chem. 2003, 278:50497-50505.
25. Dahlhaus R., Hines R.M., Eadie B.D., Kannangara T.S., Hines D.J., Brown C.E., Christie B.R., El-Husseini A. Overexpression of the cell adhesion protein neuroligin-1 induces learning deficits and impairs synaptic plasticity by altering the ratio of excitation to inhibition in the hippocampus. Hippocampus 2010, 20:305-322.
26. Dalva M.B., Takasu M.A., Lin M.Z., Shamah S.M., Hu L., Gale N.W., Greenberg M.E. EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell 2000, 103:945-956.
27. Dalva M.B., McClelland A.C., Kayser M.S. Cell adhesion molecules: signalling functions at the synapse. Nat. Rev. Neurosci. 2007, 8:206-220.
28. Dinamarca M.C., Colombres M., Cerpa W., Bonansco C., Inestrosa N.C. β-amyloid oligomers affect the structure and function of the postsynaptic region: role of the Wnt signaling pathway. Neurodegen. Dis. 2008, 5:149-152.
29. Dinamarca M.C., Weinstein D., Monasterio O., Inestrosa N.C. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?. Biochemistry 2011, 50:8127-8137.
30. Dinamarca M.C., Rios J.A., Inestrosa N.C. Postsynaptic receptors for amyloid-β oligomers as mediators of neuronal damage in Alzheimer's disease. Front. Physiol. 2012, 3:464.
31. Fannon A.M., Colman D.R. Amodel for central synaptic junctional complex formation based on the differential adhesive specificities of the cadherins. Neuron 1996, 17:423-434.
32. Feng J., Schroer R., Yan J., Song W., Yang C., Bockholt A., Cook J.E.H., Skinner C., Schwartz C.E., Sommer S.S. High frequency of neurexin 1β signal peptide structural variants in patients with autism. Neurosci. Lett. 2006, 409:10-13.
33. Gilbert M., Smith J., Roskams A.-J., Auld V.J. Neuroligin 3 is a vertebrate gliotactin expressed in the olfactory ensheathing glia, a growth-promoting class of macroglia. Glia 2001, 34:151-164.
34. Gilbert M.M., Auld V.J. Evolution of CLAMS (cholinesterase-like adhesion molecules): structure and function during development. Front. Biosci. 2005, 10:2177-2192.
35. Gimbel D.A., Nygaard H.B., Coffey E.E., Gunther E.C., Lauren J., Gimbel Z.A., Strittmatter S.M. Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J.Neurosci. 2010, 30:6367-6374.
36. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 1984, 120:885-890.
37. Glenner G.G., Wong C.W. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 1984, 122:1131-1135.
38. Graf E.R., Zhang X., Jin S.X., Linhoff M.W., Craig A.M. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 2004, 119:1013-1026.
39. Graf E.R., Kang Y., Hauner A.M., Craig A.M. Structure function and splice site analysis of the synaptogenic activity of the neurexin-1 β LNS domain. J.Neurosci. 2006, 26:4256-4265.
40. Haass C., Hung A., Selkoe D. Processing of β-amyloid precursor protein in microglia and astrocytes favors a localization in internal vesicles over constitutive secretion. J.Neurosci. 1991, 11:3783-3793.
41. Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nat. Rev. Mol. Cell Biol. 2007, 8:101-112.
42. Hall A.C., Lucas F.R., Salinas P.C. Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell 2000, 100:525-535.
43. Heindel W., Jernigan T.L., Archibald S.L., Achim C.L., Masliah E., Wiley C.A. The relationship of quantitative brain magnetic resonance imaging measures to neuropathologic indices of human immunodeficiency virus infection. Arch. Neurol. 1994, 51:1129-1135.
44. Hines R.M., Wu L., Hines D.J., Steenland H., Mansour S., Dahlhaus R., Singaraja R.R., Cao X., Sammler E., Hormuzdi S.G., Zhuo M., El-Husseini A. Synaptic imbalance, stereotypies, and impaired social interactions in mice with altered neuroligin 2 expression. J.Neurosci. 2008, 28:6055-6067.
45. Hirao K., Hata Y., Ide N., Takeuchi M., Irie M., Yao I., Deguchi M., Toyoda A., Südhof T.C., Takai Y. Anovel multiple PDZ domain-containing molecule interacting with N-methyl-D-aspartate receptors and neuronal cell adhesion proteins. J.Biol. Chem. 1998, 273:21105-21110.
46. Hoffman R.C., Jennings L.L., Tsigelny I., Comoletti D., Flynn R.E., Südhof T.C., Taylor P. Structural characterization of recombinant soluble rat neuroligin 1: mapping of secondary structure and glycosylation by mass spectrometry. Biochemistry 2004, 43:1496-1506.
47. Holmquist M. α/β-Hydrolase fold enzymes: structures, functions and mechanisms. Curr. Protein Pept. Sci. 2000, 1:209-235.
48. Honer W.G., Dickson D.W., Gleeson J., Davies P. Regional synaptic pathology in Alzheimer's disease. Neurobiol. Aging 1992, 13:375-382.
49. Hong M., Zhukareva V., Vogelsberg-Ragaglia V., Wszolek Z., Reed L., Miller B.I., Geschwind D.H., Bird T.D., McKeel D., Goate A., Morris J.C., Wilhelmsen K.C., Schellenberg G.D., Trojanowski J.Q., Lee V.M. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 1998, 282:1914-1917.
50. Hsia A.Y., Masliah E., McConlogue L., Yu G.-Q., Tatsuno G., Hu K., Kholodenko D., Malenka R.C., Nicoll R.A., Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. U.S.A 1999, 96:3228-3233.
51. Hu N.-W., Smith I.M., Walsh D.M., Rowan M.J. Soluble amyloid-β peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction invivo. Brain 2008, 131:2414-2424.
52. Hung A.Y., Selkoe D.J. Selective ectodomain phosphorylation and regulated cleavage of β-amyloid precursor protein. EMBO J. 1994, 13:534-542.
53. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B.J., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., Heutink P. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705.
54. Ichtchenko K., Hata Y., Nguyen T., Ullrich B., Missler M., Moomaw C., Südhof T.C. Neuroligin 1: a splice site-specific ligand for β-neurexins. Cell 1995, 81:435-443.
55. Ichtchenko K., Nguyen T., Südhof T.C. Structures, alternative splicing, and neurexin binding of multiple neuroligins. J.Biol. Chem. 1996, 271:2676-2682.
56. Inestrosa N.C., Alvarez A., Perez C.A., Moreno R.D., Vicente M., Linker C., Casanueva O.I., Soto C., Garrido J. Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 1996, 16:881-891.
57. Ingelsson M., Fukumoto H., Newell K.L., Growdon J.H., Hedley-Whyte E.T., Frosch M.P., Albert M.S., Hyman B.T., Irizarry M.C. Early β-amyloid accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 2004, 62:925-931.
58. Iqbal K., Zaidi T., Thompson C.H., Merz P.A., Wisniewski H.M. Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition. Acta Neuropathol. 1984, 62:167-177.
59. Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., Bourgeron T. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 2003, 34:27-29.
60. Jarrett J.T., Berger E.P., Lansbury P.T. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993, 32:4693-4697.
61. Joachim C.L., Morris J.H., Kosik K.S., Selkoe D.J. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders. Ann. Neurol. 1987, 22:514-520.
62. Jung S.Y., Kim J., Kwon O.B., Jung J.H., An K., Jeong A.Y., Lee C.J., Choi Y.B., Bailey C.H., Kandel E.R., Kim J.H. Input-specific synaptic plasticity in the amygdala is regulated by neuroligin-1 via postsynaptic NMDA receptors. Proc. Natl. Acad. Sci. U.S.A 2010, 107:4710-4715.
63. Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., Sisodia S., Malinow R. APP processing and synaptic function. Neuron 2003, 37:925-937.
64. Kattenstroth G., Tantalaki E., Südhof T.C., Gottmann K., Missler M. Postsynaptic N-methyl-D-aspartate receptor function requires α-neurexins. Proc. Natl. Acad. Sci. U.S.A 2004, 101:2607-2612.
65. Kim J., Jung S.Y., Lee Y.K., Park S., Choi J.S., Lee C.J., Kim H.S., Choi Y.B., Scheiffele P., Bailey C.H., Kandel E.R., Kim J.H. Neuroligin-1 isrequired for normal expression of LTP and associative fear memory in the amygdala of adult animals. Proc. Natl. Acad. Sci. U.S.A 2008, 105:9087-9092.
66. Kim J., Chang A., Dudak A., Federoff H.J., Lim S.T. Characterization of nectin processing mediated by presenilin-dependent γ-secretase. J.Neurochem. 2011, 119:945-956.
67. Klyubin I., Walsh D.M., Lemere C.A., Cullen W.K., Shankar G.M., Betts V., Spooner E.T., Jiang L., Anwyl R., Selkoe D.J., Rowan M.J. Amyloid β protein immunotherapy neutralizes amyloid β oligomers that disrupt synaptic plasticity invivo. Nat. Med. 2005, 11:556-561.
68. Koffie R.M., Meyer-Luehmann M., Hashimoto T., Adams K.W., Mielke M.L., Garcia-Alloza M., Micheva K.D., Smith S.J., Kim M.L., Lee V.M., Hyman B.T., Spires-Jones T.L. Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc. Natl. Acad. Sci. U.S.A 2009, 106:4012-4017.
69. Koh J., Yang L., Cotman C. β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 1990, 533:315-320.
70. Kudo W., Lee H.P., Smith M.A., Zhu X., Matsuyama S., Lee H.G. Inhibition of Bax protects neuronal cells from oligomeric Aβ neurotoxicity. Cell Death Dis. 2012, 3:e309.
71. Kurschner C., Mermelstein P.G., Holden W.T., Surmeier D.J. CIPP, a novel multivalent PDZ domain protein, selectively interacts with Kir4.0 family members, NMDA receptor subunits, neurexins, and neuroligins. Mol. Cell. Neurosci. 1998, 11:161-172.
72. Lassmann H., Weiler R., Fischer P., Bancher C., Jellinger K., Floor E., Danielczyk W., Seitelberger F., Winkler H. Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles. Neuroscience 1992, 46:1-8.
73. Lauren J., Gimbel D.A., Nygaard H.B., Gilbert J.W., Strittmatter S.M. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Nature 2009, 457:1128-1132.
74. Mabb A.M., Ehlers M.D. Ubiquitination in postsynaptic function and plasticity. Annu. Rev. Cell Dev. Biol. 2010, 26:179-210.
75. Malenka R.C., Bear M.F. LTP and LTD: an embarrassment of riches. Neuron 2004, 44:5-21.
76. Malinverno M., Carta M., Epis R., Marcello E., Verpelli C., Cattabeni F., Sala C., Mulle C., Di Luca M., Gardoni F. Synaptic localization and activity of ADAM10 regulate excitatory synapses through N-cadherin cleavage. J.Neurosci. 2010, 30:16343-16355.
77. Marambaud P., Shioi J., Serban G., Georgakopoulos A., Sarner S., Nagy V., Baki L., Wen P., Efthimiopoulos S., Shao Z., Wisniewski T., Robakis N.K. Apresenilin-1/γ-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 2002, 21:1948-1956.
78. Martinez-Mir A., González-Pérez A., Gayán J., Antúnez C., Marín J., Boada M., Lopez-Arrieta J.M., Fernández E., Ramírez-Lorca R., Sáez M.E., Ruiz A., Scholl F.G., Real L.M. Genetic study of neurexin and neuroligin genes in Alzheimer's disease. J.Alzheimers Dis. 2013, 35:403-412.
79. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A 1985, 82:4245-4249.
80. 11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006, 67:446-452.
81. Missler M., Südhof T.C. Neurexins: three genes and 1001 products. Trends Genet. 1998, 14:20-26.
82. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L. High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J.Neurosci. 2000, 20:4050-4058.
83. Nguyen T., Südhof T.C. Binding properties of neuroligin 1 and neurexin 1β a reveal function as heterophilic cell adhesion molecules. J.Biol. Chem. 1997, 272:26032-26039.
84. Peixoto R.T., Kunz P.A., Kwon H., Mabb A.M., Sabatini B.L., Philpot B.D., Ehlers M.D. Transsynaptic signaling by activity-dependent cleavage of neuroligin-1. Neuron 2012, 76:396-409.
85. Perdahl E., Adolfsson R., Alafuzoff I., Albert K., Nestler E. Synapsin I (protein I) in different brain regions in senile dementia of Alzheimer type and in multi-infarct dementia. J.Neur. Transm. 1984, 60:133-141.
86. Philibert R.A., Winfield S.L., Sandhu H.K., Martin B.M., Ginns E.I. The structure and expression of the human neuroligin-3 gene. Gene 2000, 246:303-310.
87. Plant L.D., Boyle J.P., Smith I.F., Peers C., Pearson H.A. The production of amyloid β peptide is a critical requirement for the viability of central neurons. J.Neurosci. 2003, 23:5531-5535.
88. Reddy P.H., Mani G., Park B.S., Jacques J., Murdoch G., Whetsell W., Kaye J., Manczak M. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. J.Alzheimers Dis. 2005, 7:103-117.
89. Rees T., Hammond P.I., Soreq H., Younkin S., Brimijoin S. Acetylcholinesterase promotes β-amyloid plaques in cerebral cortex. Neurobiol. Aging 2003, 24:777-787.
90. Restituito S., Khatri L., Ninan I., Mathews P.M., Liu X., Weinberg R.J., Ziff E.B. Synaptic autoregulation by metalloproteases and γ-secretase. J.Neurosci. 2011, 31:12083-12093.
91. Roher A.E., Lowenson J.D., Clarke S., Wolkow C., Wang R., Cotter R.J., Reardon I.M., Zürcher-Neely H.A., Heinrikson R.L., Ball M.J. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J.Biol. Chem. 1993, 268:3072-3083.
92. Ronicke R., Mikhaylova M., Ronicke S., Meinhardt J., Schroder U.H., Fandrich M., Reiser G., Kreutz M.R., Reymann K.G. Early neuronal dysfunction by amyloid β oligomers depends on activation of NR2B-containing NMDA receptors. Neurobiol. Aging 2011, 32:2219-2228.
93. Rowan M.J., Klyubin I., Wang Q., Hu N.W., Anwyl R. Synaptic memory mechanisms: Alzheimer's disease amyloid β-peptide-induced dysfunction. Biochem. Soc. Trans. 2007, 35:1219-1223.
94. Saura C.A., Servián-Morilla E., Scholl F.G. Presenilin/γ-secretase regulates neurexin processing at synapses. PLoS One 2011, 6:e19430.
95. Scheiffele P., Fan J., Choih J., Fetter R., Serafini T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 2000, 101:657-669.
96. Scholl F.G., Scheiffele P. Making connections: cholinesterase-domain proteins in the CNS. Trends Neurosci. 2003, 26:618-624.
97. Selkoe D.J., Podlisny M.B., Joachim C.L., Vickers E.A., Lee G., Fritz L.C., Oltersdorf T. β-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc. Natl. Acad. Sci. U.S.A 1988, 85.
98. Selkoe D.J. The cell biology of β amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 1998, 8:447-453.
99. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81:741-766.
100. Selkoe D.J. Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior. Behav. Brain Res. 2008, 192:106-113.
101. Seubert P., Oltersdorf T., Lee M.G., Barbour R., Blomquist C., Davis D.L., Bryant K., Fritz L.C., Galasko D., Thal L.J., Lieberburg I., Schenk D.B. Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature 1993, 361:260-263.
102. Shankar G.M., Bloodgood B.L., Townsend M., Walsh D.M., Selkoe D.J., Sabatini B.L. Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J.Neurosci. 2007, 27:2866-2875.
103. 2+ binding and the effects of alternative splicing. J.Biol. Chem. 2006, 281:22896-22905.
104. Shipman S.L., Nicoll R.A. Asubtype-specific function for the extracellular domain of neuroligin 1 in hippocampal LTP. Neuron 2012, 76:309-316.
105. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., Greengard P. Regulation of NMDA receptor trafficking by amyloid-β. Nat. Neurosci. 2005, 8:1051-1058.
106. Song J.-Y., Ichtchenko K., Südhof T.C., Brose N. Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Proc. Natl. Acad. Sci. U.S.A 1999, 96:1100-1105.
107. Spires T.L., Meyer-Luehmann M., Stern E.A., McLean P.J., Skoch J., Nguyen P.T., Bacskai B.J., Hyman B.T. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J.Neurosci. 2005, 25:7278-7287.
108. Sugita S., Khvochtev M., Südhof T.C. Neurexins are functional α-latrotoxin receptors. Neuron 1999, 22:489-496.
109. Suzuki K., Hayashi Y., Nakahara S., Kumazaki H., Prox J., Horiuchi K., Zeng M., Tanimura S., Nishiyama Y., Osawa S., Sehara-Fujisawa A., Saftig P., Yokoshima S., Fukuyama T., Matsuki N., Koyama R., Tomita T., Iwatsubo T. Activity-dependent proteolytic cleavage of neuroligin-1. Neuron 2012, 76:410-422.
110. Sze C., Troncoso J., Kawas C., Mouton P., Price D., Martin L. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J.Neuropathol. Exp. Neurol. 1997, 56:933-944.
111. Tabuchi K., Südhof T.C. Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. Genomics 2002, 79:849-859.
112. Tabuchi K., Blundell J., Etherton M.R., Hammer R.E., Liu X., Powell C.M., Südhof T.C. Aneuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
113. Taniguchi H., Gollan L., Scholl F.G., Mahadomrongkul V., Dobler E., Limthong N., Peck M., Aoki C., Scheiffele P. Silencing of neuroligin function by postsynaptic neurexins. J.Neurosci. 2007, 27:2815-2824.
114. Tannenberg R.K., Scott H.L., Tannenberg A.E., Dodd P.R. Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE e{open}4. Neurochem. Int. 2006, 49:631-639.
115. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991, 30:572-580.
116. Ullrich B., Ushkaryov Y.A., Südhof T.C. Cartography of neurexins: more than 1000 isoforms generated by alternative splicing and expressed in distinct subsets of neurons. Neuron 1995, 14:497-507.
117. Umemori H., Linhoff M.W., Ornitz D.M., Sanes J.R. FGF22 and its close relatives are presynaptic organizing molecules in the mammalian brain. Cell 2004, 118:257-270.
118. Ushkaryov Y.A., Petrenko A.G., Geppert M., Südhof T.C. Neurexins: synaptic cell surface proteins related to the α-latrotoxin receptor and laminin. Science 1992, 257:50-56.
119. Ushkaryov Y.A., Hata Y., Ichtchenko K., Moomaw C., Afendis S., Slaughter C.A., Südhof T.C. Conserved domain structure of β-neurexins. Unusual cleaved signal sequences in receptor-like neuronal cell-surface proteins. J.Biol. Chem. 1994, 269:11987-11992.
120. Varoqueaux F., Jamain S., Brose N. Neuroligin 2 is exclusively localized to inhibitory synapses. Eur. J. Cell Biol. 2004, 83:449-456.
121. Van Gool D., Carmeliet G., Triau E., Cassiman J.-J., Dom R. Appearance of localized immunoreactivity for the α4 integrin subunit and for fibronectin in brains from Alzheimer's, Lewy body dementia patients and aged controls. Neurosci. Lett. 1994, 170:71-73.
122. von Bernhardi R., Ramirez G., De Ferrari G.V., Inestrosa N.C. Acetylcholinesterase induces the expression of the β-amyloid precursor protein in glia and activates glial cells in culture. Neurobiol. Dis. 2003, 14:447-457.
123. Weidemann A., König G., Bunke D., Fischer P., Salbaum J.M., Masters C.L., Beyreuther K. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 1989, 57:115-126.
124. Wood J.G., Mirrat S.S., Pollock N.J., Bindert L.I. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (X). Proc. Natl. Acad. Sci. U.S.A 1986, 83:4040-4043.
125. Wright S., Malinin N.L., Powell K.A., Yednock T., Rydel R.E., Griswold-Prenner I. α2β1 and αVβ1 integrin signaling pathways mediate amyloid-β-induced neurotoxicity. Neurobiol. Aging 2007, 28:226-237.
126. Ylisaukko-oja T., Rehnstrom K., Auranen M., Vanhala R., Alen R., Kempas E., Ellonen P., Turunen J.A., Makkonen I., Riikonen R., Nieminen-von Wendt T., von Wendt L., Peltonen L., Jarvela I. Analysis of four neuroligin genes as candidates for autism. Eur. J. Hum. Genet. 2005, 13:1285-1292.
127. Zeev-Ben-Mordehai T., Rydberg E.H., Solomon A., Toker L., Auld V.J., Silman I., Botti S., Sussman J.L. The intracellular domain of the drosophila cholinesterase-like neural adhesion protein, gliotactin, is natively unfolded. Prot. Struct. Funct. Bioinformat. 2003, 53:758-767.